← Open Payments lookup

KELLY PETERSON: Open Payments

NPI 1770270977 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$634 in 20 payments from 10 companies in 2025. Trend: 2023 $205 · 2024 $803 · 2025 $634

Food & beverage: $634
CompanyPaymentsAmount
Novo Nordisk Inc3$165
Daiichi Sankyo Inc.1$127
Amgen Inc.5$79
PFIZER INC.3$75
Alnylam Pharmaceuticals Inc.2$52
Novartis Pharmaceuticals Corporation2$43
Boston Scientific Corporation1$31
Merck Sharp & Dohme LLC1$24
INOGEN, INC.1$22
ABIOMED1$17

Products named: DATROWAY, Ozempic, Repatha, AMVUTTRA, VYNDAQEL, Wegovy, LEQVIO, WATCHMAN FLX.

Industry payments across NV — which companies pay providers there.